# Desano Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/desano-pharma

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.desano.com
- Latest round: Series A (Jan 1, 2011)
- Investors on record: 1

## About

Founded in 1996 and based in Shanghai, China, Desano Pharma is a pharmaceutical company that focuses on the research and development of anticancer drugs. In 2014, the company established the National Anti-HIV Drug Engineering Technology Research Center. In 2022, it obtained the control rights of Pfizer and Merck's new crown oral drugs. Desano Pharma has five production bases in Shanghai, Jiangsu, and Jiangxi for pharmaceutical preparations, APIs, and intermediates that meet cGMP and EHS requirements.

The company's main products include antiviral drugs, steroid hormone drugs and nucleic acid drugs. Its products are applied to diseases such as AIDS and COVID-19.

## Funding rounds

- Series A, Jan 1, 2011 — Greenwoods Asset Management

## Investors

- Greenwoods Asset Management (https://capitalatlas.ai/funds/greenwoods-asset-management) — Series A